LAG-3 and PD-1 Inhibitors for Esophageal and Gastroesophageal Junction Cancer: A Phase Ib Trial
Combining Gemcitabine With CXCR4, PD-1 Inhibitors for Pancreatic Ductal Adenocarcinoma
ARC-8: Targeting CD73 Inhibition in mPDAC With Quemliclustat and Zimberelimab